Is it Possible to Accurately Determine Content of Botulinum Neurotoxin Type A in Drug Products?
Open Access
- 1 July 2010
- journal article
- editorial
- Published by Springer Nature in Drugs in R&D
- Vol. 10 (2) , 91-92
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Content of Botulinum Neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture®Drugs in R&D, 2010
- Role for standards in assays of botulinum toxins: international collaborative study of three preparations of botulinum type A toxinBiologicals, 2003
- Therapeutic botulinum type a toxin: Factors affecting potencyToxicon, 1996
- Immunological detection of Clostridium botulinum toxin type A in therapeutic preparationsJournal of Immunological Methods, 1995
- Dose standardisation of botulinum toxinThe Lancet, 1994